<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1563715" disease_type="Disease or Syndrome" abbrv="">Andersen-Tawil syndrome</z:e> (ATS1)-associated <z:hpo ids='HP_0004756'>ventricular tachycardias</z:hpo> (VTs) are initiated by frequent, <z:hpo ids='HP_0002900'>hypokalemia</z:hpo>-exacerbated, premature ventricular activity (<z:chebi fb="10" ids="53706">PVA</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>We previously demonstrated that a guinea pig model of drug-induced ATS1 (DI-ATS1) evidenced increased <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> from regions with high <z:chebi fb="0" ids="29101">Na(+)</z:chebi>/Ca(2+)-exchange expression </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: Therefore, we hypothesize that reduced cytosolic <z:chebi fb="0" ids="29101">Na(+)</z:chebi> entry through either cardiac isoform of or <z:chebi fb="2" ids="9506">tetrodotoxin</z:chebi> (<z:chebi fb="0" ids="9506">TTX</z:chebi>)-sensitive <z:chebi fb="0" ids="29101">Na(+)</z:chebi> channels during DI-ATS1 can ameliorate <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> burden </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: DI-ATS1 was induced with 10 μM BaCl(2) and 2 mM extracellular <z:chebi fb="0" ids="29103">K(+)</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Ca(2+) transients and conduction velocity (CV) were optically mapped with <z:chebi fb="0" ids="52084">indo-1</z:chebi> and di-4-ANEPPS, respectively, from Langendorff-perfused guinea pig ventricles </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Nonselective <z:chebi fb="0" ids="29101">Na(+)</z:chebi> channel blockade with 1 μM flecainide reduced amplitude (Ca(A)), slowed left ventricular CV, reduced tissue excitability, and abolished the incidence of VT while decreasing the incidence of <z:chebi fb="10" ids="53706">PVA</z:chebi> relative to DI-ATS1 </plain></SENT>
<SENT sid="6" pm="."><plain>Selective, <z:chebi fb="0" ids="9506">TTX</z:chebi>-sensitive <z:chebi fb="0" ids="29101">Na(+)</z:chebi> channel blockade with <z:chebi fb="0" ids="9506">TTX</z:chebi> (100 nM) during DI-ATS1 decreased Ca(A) and decreased the inducibility of VTs and <z:chebi fb="10" ids="53706">PVA</z:chebi> relative to DI-ATS1 without slowing CV </plain></SENT>
<SENT sid="7" pm="."><plain>Ranolazine altered Ca(A), left ventricular CV, tissue excitability, and reduced inducibility of VT and <z:chebi fb="10" ids="53706">PVA</z:chebi> in a concentration-dependent manner </plain></SENT>
<SENT sid="8" pm="."><plain>None of the aforementioned interventions altered diastolic Ca(2+) levels or Ca(2+) transient decay time constant </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: These data suggest that cytosolic <z:chebi fb="0" ids="29101">Na(+)</z:chebi> entry and its modulation of Ca(2+) handling are necessary for arrhythmogenesis </plain></SENT>
<SENT sid="10" pm="."><plain>During the loss of inward-rectifier <z:chebi fb="0" ids="29103">K(+)</z:chebi> current function, not only <z:chebi fb="0" ids="29101">Na(+)</z:chebi>/Ca(2+)-exchange dominance but <z:chebi fb="0" ids="29101">Na(+)</z:chebi> flux may determine <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> burden </plain></SENT>
<SENT sid="11" pm="."><plain>Therefore, selective inhibition of <z:chebi fb="0" ids="9506">TTX</z:chebi>-sensitive <z:chebi fb="0" ids="29101">Na(+)</z:chebi> channels may offer a potential therapeutic target to alleviate <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> during states of Ca(2+) overload secondary to loss of inward-rectifier <z:chebi fb="0" ids="29103">K(+)</z:chebi> current function without compromising the excitability reserve </plain></SENT>
</text></document>